Format

Send to

Choose Destination
J Endocr Soc. 2018 Aug 3;2(10):1100-1108. doi: 10.1210/js.2018-00156. eCollection 2018 Oct 1.

Xq26.3 Duplication in a Boy With Motor Delay and Low Muscle Tone Refines the X-Linked Acrogigantism Genetic Locus.

Author information

1
Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland.
2
Department of Endocrinology and Diabetes, Lady Cilento Children's Hospital, Brisbane, Australia.
3
School of Medicine, University of Queensland, Brisbane, Australia.
4
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
5
St George's University of London, London, United Kingdom.
6
Southwest Thames Regional Genetics Centre, St George's Healthcare NHS Trust, London, United Kingdom.
7
Department of Metabolic Medicine, Lady Cilento Children's Hospital, Brisbane, Australia.
8
Griffith University, School of Medicine, Gold Coast, Australia.
9
Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas.
10
Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
11
Texas Children's Hospital, Houston, Texas.
12
Mater Medical Research Institute, University of Queensland, Brisbane, Australia.

Abstract

We describe a 4-year-old boy with developmental delay who was found to carry by clinical grade (CG) molecular cytogenetics (MCs) a chromosome Xq26 microduplication. The report prompted a referral of the patient for possible X-linked acrogigantism (X-LAG), a well-defined condition (MIM300942) due to chromosomal microduplication of a nearby region. The patient was evaluated clinically and investigated for endocrine abnormalities related to X-LAG and not only did he not have acrogigantism, but his growth parameters and other hormones were all normal. We then performed high definition MCs and the duplication copy number variant (CNV) was confirmed to precisely map outside the X-LAG critical region and definitely did not harbor the X-LAG candidate gene, GPR101. The patient's phenotype resembled that of other patients with Xq26 CNVs. The case is instructive for the need for high definition MCs when CG MCs' results are inconsistent with the patient's phenotype. It is also useful for further supporting the contention that GPR101 is the gene responsible for X-LAG.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center